Key information

Application number
202603962
Trademark text
DECNUPAZ
Case type
National mark
Status
14.10.2022 Etter omdanning
Filed
10.12.2021
Priority
11.06.2021 US 90769164
Registration number
341292
Registered
14.10.2022
Published in the Gazette
13.04.2026
Grace period start date, cf. Trademarks Act Section 37
25.01.2023
Renewal deadline
10.12.2031
Trademark category
Trademark
Type of Mark
Word Mark
Goods/services (NICE class)
5
Acquired distinctiveness
No
Applicant
ImmunoGen, Inc. (US)
Owner
ImmunoGen, Inc. (US)
Agent
ZACCO NORWAY AS (NO)

List of products

Class 5
Legemidler til menneskelig bruk, nemlig farmasøytiske preparater for behandling av kreft; legemidler til menneskelig bruk, nemlig farmasøytiske preparater for behandling av onkologiske sykdommer, lidelser og tilstander.

Documents

 Download files (2)
Date
 Date Doc. No. Process Case number In/Out Journal description To/from
 10.04.2026 02-01 Saksbehandling 202603962 UT Oversendelse reg. brev omdanning ZACCO NORWAY AS
 27.03.2026 01-01 Saksbehandling 202603962 INN Søknadsskjema Varemerke ZACCO NORWAY AS

Priority

11.06.2021 US 90769164

Applicants and owners

Owners
ImmunoGen, Inc.
1 North Waukegan Road IL60064 NORTH CHICAGO US

Agent

ZACCO NORWAY AS
ZACCO NORWAY AS

Org. number: 982702887

Name and address are automatically synchronized with the Brønnøysund Register Centre.

Open in The Brønnøysund Register Centre
Postboks 488 0213 OSLO NO (OSLO Municipality, Oslo county)
Org. number: 982702887
Reference: T504630NO00

Status history

Payment history

Oppositions and appeals

No oppositions or appeals

Alteration of mark

No alteration of mark

Liens and licences

No liens or licenses registered

Gazette entries

No Gazette entries foundOnly events from 2024.03.04 and onwards are shown.